-
Review articleImplementation of pharmacogenetics for treatment of patients with acute lymphoblastic leukemia
27-39https://doi.org/10.18413/rrpharmacology.10.382
17-06-2024
Abstract: 299
|
PDF: 174 |
HTML: 152 |
-
Experimental PharmacologyAn effective way for targeting EGFR-mediated carcinogenesis: an in vitro study
17-26https://doi.org/10.18413/rrpharmacology.10.453
12-06-2024
Abstract: 329
|
PDF: 162 |
HTML: 123 |
-
Experimental PharmacologyDevelopment of a transcutaneous form of desloratadine
57-64https://doi.org/10.18413/rrpharmacology.10.487
28-06-2024
Abstract: 371
|
PDF: 140 |
HTML: 110 |
-
Experimental PharmacologyFIMD based model validation approaches for Rheumatoid arthritis and associated cardiovascular complications: an attempt towards translational competence
73-82https://doi.org/10.18413/rrpharmacology.10.446
30-06-2024
Abstract: 189
|
PDF: 106 |
HTML: 65 |
Supplementary material 1: 0 |
Supplementary material 2: 0 |
Supplementary material 3: 0 |
Supplementary material 4: 0 |
-
Experimental PharmacologyAssessment of the correction of neuroretinal changes using 2-ethyl-6-methyl-3-hydroxypyridinium N-acetyltaurinate in the modeling of POAG
107-117https://doi.org/10.18413/rrpharmacology.10.477
30-06-2024
Abstract: 433
|
PDF: 110 |
HTML: 114 |
-
Experimental PharmacologySynthesis and pharmacological activity of various organic and inorganic salts of phenyl derivatives of imidazobenzimidazole
119-133https://doi.org/10.18413/rrpharmacology.10.465
30-06-2024
Abstract: 273
|
PDF: 106 |
HTML: 358 |
-
Experimental PharmacologyLong-term administration of the α-amylase inhibitor acarbose effective against type 2 diabetes symptoms in C57BL/6 mice
65-72https://doi.org/10.18413/rrpharmacology.10.455
28-06-2024
Abstract: 199
|
HTML: 282 |
PDF: 133 |
-
Experimental PharmacologyStudy of the neuroprotective properties of the heteroreceptor EPOR/CD131 agonist of peptide structure in tau-proteinopathy modeling
41-47https://doi.org/10.18413/rrpharmacology.10.492
17-06-2024
Abstract: 405
|
PDF: 142 |
HTML: 126 |
-
Experimental PharmacologyIntranasal administration of ghrelin receptor antagonist [D-Lys-3]-GHRP-6 reduces the manifestations of impulsivity and compulsivity induced by maternal deprivation in rats
97-105https://doi.org/10.18413/rrpharmacology.10.448
30-06-2024
Abstract: 250
|
PDF: 165 |
HTML: 113 |
-
Experimental PharmacologyIdentification and synthesis of metabolites of the new 4.5-dihydroisoxazol-5-carboxamide derivate
83-95https://doi.org/10.18413/rrpharmacology.10.482
30-06-2024
Abstract: 884
|
PDF: 136 |
HTML: 129 |
-
Experimental PharmacologyProtective effects of thymogen analogues, modified by D-alanine, in hydrazine liver damage
11-16https://doi.org/10.18413/rrpharmacology.10.458
07-06-2024
Abstract: 334
|
PDF: 159 |
HTML: 211 |
-
Clinical PharmacologyAssessment of VEGF and TNF-alpha levels in patients with an unexpectedly poor and suboptimal response during the treatment of infertility using ART methods
1-9https://doi.org/10.18413/rrpharmacology.10.437
18-04-2024
Abstract: 387
|
PDF: 277 |
HTML: 165 |
-
Clinical PharmacologyApproaches to therapy Amlodipine/Indapamide/Perindopril therapy of high arterial hypertension in ischemic heart disease patients with chronic kidney disease stage 1-3 after coronary stenting
49-55https://doi.org/10.18413/rrpharmacology.10.475
13-06-2024
Abstract: 359
|
PDF: 174 |
HTML: 144 |
Language
Русский
English
 |
Journal "Research Results in Pharmacology" (ISSN 2658-381X) The Founder: Federal State Autonomous Educational Institution of Higher Education "Belgorod National Research University" The Publisher: Federal State Autonomous Educational Institution of Higher Education "Belgorod National Research University" Chief Editor: Pokrovskii M.V. Editors Office: e-mail: rr_pharmacology@bsuedu.ru, phone: +7 (4722) 30-13-73. The Journal registered by the Federal Service for Supervision of Communications, Information Technology and Mass Media (Roskomnadzor). |
|
